Collegium Pharmaceutical Gains Attention on ADHD Portfolio Strength After Q1 Beat ACCO Q1 2026 Earnings EPS Surprise Drives Cautious Optimism Amid Modest Stock Decline Trumps Tariff Defeats in Court Highlight Congressional Abdication of Trade Authority